Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FONAR Co. stock logo
FONR
FONAR
$14.40
$12.94
$12.00
$18.68
$89.32M117,013 shs15,580 shs
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
$2.44
-3.6%
$2.69
$1.92
$4.21
$87.08M0.74248,321 shs75,383 shs
Myomo, Inc. stock logo
MYO
Myomo
$2.86
-6.5%
$4.15
$2.76
$7.17
$86.52M1.68382,518 shs1.07 million shs
Vaso Co. stock logo
VASO
Vaso
$0.14
-0.9%
$0.13
$0.11
$0.32
$23.97M1.5593,216 shs2,000 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FONAR Co. stock logo
FONR
FONAR
0.00%+1.91%+16.98%-1.17%-7.63%
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
0.00%-6.15%-15.57%+3.39%+22.61%
Myomo, Inc. stock logo
MYO
Myomo
0.00%-8.04%-41.39%-43.59%-16.13%
Vaso Co. stock logo
VASO
Vaso
0.00%-1.16%+1.56%-1.16%-46.29%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
FONAR Co. stock logo
FONR
FONAR
2.3081 of 5 stars
0.05.00.00.03.00.81.9
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
3.4257 of 5 stars
3.85.00.00.03.01.70.6
Myomo, Inc. stock logo
MYO
Myomo
2.241 of 5 stars
3.53.00.00.00.62.50.6
Vaso Co. stock logo
VASO
Vaso
1.1586 of 5 stars
0.05.00.00.01.51.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
FONAR Co. stock logo
FONR
FONAR
0.00
N/AN/AN/A
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
3.50
Strong Buy$5.40121.31% Upside
Myomo, Inc. stock logo
MYO
Myomo
3.00
Buy$9.50232.17% Upside
Vaso Co. stock logo
VASO
Vaso
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest VASO, MYO, MGRM, and FONR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/8/2025
Myomo, Inc. stock logo
MYO
Myomo
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$11.00 ➝ $10.00
3/18/2025
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$5.40
3/18/2025
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$4.00 ➝ $5.40
3/17/2025
Myomo, Inc. stock logo
MYO
Myomo
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$9.00 ➝ $11.00
3/12/2025
Myomo, Inc. stock logo
MYO
Myomo
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.50 ➝ $9.50
3/11/2025
Myomo, Inc. stock logo
MYO
Myomo
Alliance Global Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
3/11/2025
Myomo, Inc. stock logo
MYO
Myomo
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$9.00 ➝ $11.00
(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
FONAR Co. stock logo
FONR
FONAR
$103.02M0.87$3.01 per share4.78$25.62 per share0.56
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
$365.00K238.57N/AN/A$0.43 per share5.67
Myomo, Inc. stock logo
MYO
Myomo
$19.24M4.50N/AN/A$0.34 per share8.41
Vaso Co. stock logo
VASO
Vaso
$83.05M0.29$0.03 per share4.29$0.14 per share0.97
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
FONAR Co. stock logo
FONR
FONAR
$10.57M$1.2512.52N/A7.68%4.94%3.70%N/A
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
-$13.74M-$0.45N/AN/AN/AN/A-130.90%-106.38%8/13/2025 (Estimated)
Myomo, Inc. stock logo
MYO
Myomo
-$8.15M-$0.23N/AN/AN/A-33.22%-86.30%-52.72%8/5/2025 (Estimated)
Vaso Co. stock logo
VASO
Vaso
$4.80MN/A0.00N/A-0.14%-0.45%-0.16%8/12/2025 (Estimated)

Latest VASO, MYO, MGRM, and FONR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q3 2025
FONAR Co. stock logo
FONR
FONAR
N/A$0.37N/A$0.37N/AN/A
5/15/2025Q1 2025
Vaso Co. stock logo
VASO
Vaso
N/A-$0.01N/A-$0.01N/A$19.46 million
5/14/2025Q1 2025
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
-$0.12-$0.10+$0.02-$0.10N/AN/A
3/31/2025Q4 2024
Vaso Co. stock logo
VASO
Vaso
N/A$0.01N/A$0.01N/A$27.04 million
3/12/2025Q4 2024
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
-$0.11-$0.08+$0.03-$0.08N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
FONAR Co. stock logo
FONR
FONAR
N/AN/AN/AN/AN/A
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
N/AN/AN/AN/AN/A
Myomo, Inc. stock logo
MYO
Myomo
N/AN/AN/AN/AN/A
Vaso Co. stock logo
VASO
Vaso
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
FONAR Co. stock logo
FONR
FONAR
N/A
11.24
9.45
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
N/A
7.31
7.31
Myomo, Inc. stock logo
MYO
Myomo
N/A
2.10
1.62
Vaso Co. stock logo
VASO
Vaso
N/A
1.42
1.39

Institutional Ownership

CompanyInstitutional Ownership
FONAR Co. stock logo
FONR
FONAR
50.64%
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
0.45%
Myomo, Inc. stock logo
MYO
Myomo
44.99%
Vaso Co. stock logo
VASO
Vaso
N/A

Insider Ownership

CompanyInsider Ownership
FONAR Co. stock logo
FONR
FONAR
1.55%
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
28.10%
Myomo, Inc. stock logo
MYO
Myomo
4.54%
Vaso Co. stock logo
VASO
Vaso
44.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
FONAR Co. stock logo
FONR
FONAR
4806.20 million6.19 millionNot Optionable
Monogram Orthopaedics, Inc. stock logo
MGRM
Monogram Orthopaedics
2835.69 million24.67 millionNot Optionable
Myomo, Inc. stock logo
MYO
Myomo
9030.25 million28.87 millionNot Optionable
Vaso Co. stock logo
VASO
Vaso
260175.74 million97.51 millionNot Optionable

Recent News About These Companies

Vaso Corporation Registered Shs
Top Analyst Reports for Apple, Philip Morris & Sony
Inflammation during menstrual cycle may trigger VOEs: Study
Vasomedical reports Q4 revenue $27M vs. $21.9M last year

New MarketBeat Followers Over Time

Media Sentiment Over Time

FONAR stock logo

FONAR NASDAQ:FONR

$14.40 0.00 (0.00%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$14.50 +0.10 (+0.69%)
As of 07:48 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Monogram Orthopaedics stock logo

Monogram Orthopaedics NASDAQ:MGRM

$2.44 -0.09 (-3.56%)
Closing price 05/30/2025 04:00 PM Eastern
Extended Trading
$2.41 -0.03 (-1.23%)
As of 07:48 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas.

Myomo stock logo

Myomo NYSEAMERICAN:MYO

$2.86 -0.20 (-6.54%)
Closing price 05/30/2025 04:10 PM Eastern
Extended Trading
$2.95 +0.09 (+3.15%)
As of 08:36 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Vaso stock logo

Vaso OTCMKTS:VASO

$0.14 0.00 (-0.94%)
As of 05/30/2025 03:59 PM Eastern

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.